BATS BZX Real-Time Price
As of 2:56pm ET
| +0.70 / +0.95%|
The 20 analysts offering 12-month price forecasts for AbbVie have a median target of 71.50, with a high estimate of 95.00 and a low estimate of 60.00. The median estimate represents a -4.30% decrease from the last price of 74.71.
The current consensus among 22 polled investment analysts is to Hold stock in AbbVie. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.